-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Lancet: Mediterranean diet does better at preventing cardiovascular disease recurrence and dea.
The Mediterranean diet is a healthy, light and nutritious eating pattern that emphasizes eating more vegetables, fruits, fish, seafood, legumes, nuts, followed by grains, and cooking with vegetable oils (containing unsaturated fatty acids) rather than animal oils (containing saturated fatty acids) fatty acids), especially olive o.
The Mediterranean diet and low-fat diet, which have been shown to be effective in primary prevention of cardiovascular disease (preventing disease in people without cardiovascular disease), are not effective in secondary prevention of cardiovascular disease (reducing cardiovascular risk-related diseases) recurrence and mortality)?
On May 4, 2022, researchers from Córdoba University and Reina Sofia University Hospital in Spain published a paper titled "Long-term secondary prevention of cardiovascular disease with a Mediterranean diet" in the top international medical journal The Lanc.
The study included 1,002 patients with confirmed coronary heart disease, aged 20-75 years, with an average age of 55 years, including 827 males and 175 femal.
They were randomly assigned 1:1 to the Mediterranean diet group (502 people) and the low-fat diet group (500 people) and were followed for 7 yea.
Notably, their diets were matched by an independent team of nutritionists, and neither the entire clinical study team (including physicians, investigators, and clinical endpoint committee members) nor the participants themselves knew which one they were followi.
The primary endpoint of the clinical trial was the occurrence of major cardiovascular events, including myocardial infarction, ischemic stroke, peripheral arterial disease, and cardiovascular-related dea.
Results of the clinical trial showed that a total of 198 participants had major cardiovascular events, including 87 in the Mediterranean diet group and 111 in the low-fat diet gro.
The Mediterranean diet is more helpful for secondary prevention of cardiovascular disea.
In addition, the effect was more pronounced in men, with 67 of 414 men on the Mediterranean diet experiencing a major cardiovascular event compared to 94 of 413 men on the low-fat di.
Cardiovascular events, compared with a low-fat diet, the Mediterranean diet was able to reduce the risk of cardiovascular disease recurrence and death in men by about one-thi.
This long-term randomized clinical trial demonstrated that a Mediterranean diet was superior to a low-fat diet in preventing major cardiovascular events in the secondary prevention of cardiovascular disease, supporting the use of the Mediterranean diet in the secondary prevention of cardiovascular disea.
<hr class="wp-block-separator is->